These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10772568)

  • 21. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell antibodies in thalassemia hemoglobinopathy patients.
    Tardtong P; Ratanasirivanich P; Chiewsilp P; Hathirat P
    Birth Defects Orig Artic Ser; 1988; 23(5B):287-9. PubMed ID: 3390554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.
    Gader AG; Al Ghumlas AK; Al-Momen AK
    Transfus Apher Sci; 2008 Dec; 39(3):199-204. PubMed ID: 18951063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte antibodies in thalassemic patients.
    Sujirachato K; Chiewsilp P; Isarangkura P
    Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transfusion requirements and mean annual hemoglobin level in thalassemia major].
    Brunengo MA; Girot R
    Nouv Rev Fr Hematol (1978); 1986; 28(5):309-13. PubMed ID: 3808940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.
    Mourad Z; Hassab H; Younan D; Abdo A
    Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The survival analysis of beta thalassemia major patients in South East of Iran.
    Roudbari M; Soltani-Rad M; Roudbari S
    Saudi Med J; 2008 Jul; 29(7):1031-5. PubMed ID: 18626536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H; Brand A
    Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).
    Metarugcheep P; Chanyawattiwongs S; Srisubat K; Pootrakul P
    J Med Assoc Thai; 2008 Jun; 91(6):889-94. PubMed ID: 18697390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.
    Guirat-Dhouib N; Mezri M; Hmida H; Mellouli F; Kaabi H; Ouderni M; Zouari B; Hmida S; Bejaoui M
    Transfus Apher Sci; 2011 Oct; 45(2):199-202. PubMed ID: 21889408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of anti-Au antibodies in polytransfused thalassemic patients].
    Moscatelli P; Burlando L; Sciarratta GV
    Pathologica; 1971; 63(925):275-9. PubMed ID: 5155559
    [No Abstract]   [Full Text] [Related]  

  • 35. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of immunoconglutinin in beta-thalassemic patients after multiple transfusions].
    Govoni F; Govoni M
    Riv Emoter Immunoematol; 1983; 30(3):282-7. PubMed ID: 6669877
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients.
    Hongeng S; Pakakasama S; Chuansumrit A; Sirachainan N; Sura T; Ungkanont A; Chuncharunee S; Jootar S; Issaragisil S
    Am J Hematol; 2007 Dec; 82(12):1095-8. PubMed ID: 17674372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemoglobin H disease in the eastern region of Saudi Arabia.
    Qadri MI; Islam SA
    Saudi Med J; 2000 Jul; 21(7):666-71. PubMed ID: 11500731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.